This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Cyramza
  • /
  • A Study of Ramucirumab (LY3009806) Plus Docetaxel ...
Clinical trial

A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer (RANGE)

Read time: 2 mins
Last updated:1st Jul 2015
Identifier: NCT02426125
Register free for full access to medthority.com